Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Bayer G3 / Tatsu System and BGMs From Other Companies

NCT01614613 is registered in ClinicalTrials.gov with Ascensia Diabetes Care as lead sponsor.

NCT NCT01614613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01614613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Bayer G3 / Tatsu System and BGMs From Other Companies
Lead sponsor
Ascensia Diabetes Care
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2012
Completion date
June 30, 2012
Enrollment
146 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes